Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ) just unveiled an announcement.
Beijing Tong Ren Tang Chinese Medicine Company Limited has announced its Annual General Meeting scheduled for June 3, 2025, where key resolutions will be discussed. These include the adoption of financial statements, re-election of directors, approval of a final dividend of HK$0.35 per share, and the re-appointment of Ernst & Young as auditors. The meeting will also address the authorization for directors to manage share-related transactions, potentially impacting the company’s market operations and shareholder value.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Company Limited is a company incorporated in Hong Kong, operating in the traditional Chinese medicine industry. It focuses on producing and distributing Chinese medicinal products, catering to both domestic and international markets.
YTD Price Performance: -0.31%
Technical Sentiment Signal: Buy
Current Market Cap: $920.4M
For a thorough assessment of 3613 stock, go to TipRanks’ Stock Analysis page.